[
  {
    "drug_target": "TCF7L2",
    "cancer": "N/A",
    "disease": "Type 2 Diabetes",
    "pmid": "34230558"
  },
  {
    "drug_target": "Genes involved in inflammatory pathways (e.g., mitogen-activated protein kinase)",
    "cancer": "N/A",
    "disease": "Type 2 Diabetes",
    "pmid": "34230558"
  },
  {
    "drug_target": "Genes involved in metabolic pathways",
    "cancer": "N/A",
    "disease": "Type 2 Diabetes",
    "pmid": "34230558"
  },
  {
    "drug_target": "Genes involved in immune regulation",
    "cancer": "N/A",
    "disease": "Type 2 Diabetes",
    "pmid": "34230558"
  },
  {
    "drug_target": "Regulatory elements within the TCF7L2 locus",
    "cancer": "N/A",
    "disease": "Type 2 Diabetes",
    "pmid": "34230558"
  },
  {
    "drug_target": "Genes co-located in biological pathways (inflammatory/metabolic)",
    "cancer": "N/A",
    "disease": "Type 2 Diabetes",
    "pmid": "34230558"
  },
  {
    "drug": "Polygenic risk score for type 2 diabetes (4891 SNPs, P<5e-04)",
    "target": "All-cause dementia",
    "cancer": null,
    "pmid": "37091584"
  },
  {
    "drug": "Polygenic risk score for type 2 diabetes (4891 SNPs, P<5e-04)",
    "target": "Mixed dementia",
    "cancer": null,
    "pmid": "37091584"
  },
  {
    "drug": "Polygenic risk score for type 2 diabetes (4891 SNPs, P<5e-04)",
    "target": "Vascular dementia",
    "cancer": null,
    "pmid": "37091584"
  },
  {
    "drug": "Polygenic risk score for type 2 diabetes (4891 SNPs, P<5e-04)",
    "target": "Alzheimer's disease",
    "cancer": null,
    "pmid": "37091584"
  },
  {
    "drug": "PPARG",
    "target": "Type 2 Diabetes",
    "cancer": "Type 2 Diabetes",
    "variant": "Associated gene",
    "pmid": "34674647"
  },
  {
    "drug": "TCF7L2",
    "target": "Type 2 Diabetes",
    "cancer": "Type 2 Diabetes",
    "variant": "Associated gene",
    "pmid": "34674647"
  },
  {
    "drug": "KCNJ11",
    "target": "Type 2 Diabetes",
    "cancer": "Type 2 Diabetes",
    "variant": "Associated gene",
    "pmid": "34674647"
  },
  {
    "drug": "SLC30A8",
    "target": "Type 2 Diabetes",
    "cancer": "Type 2 Diabetes",
    "variant": "Associated gene",
    "pmid": "34674647"
  },
  {
    "drug": "DYX1C1",
    "target": "Dyslexia",
    "cancer": "Type 2 Diabetes",
    "variant": "Associated gene",
    "pmid": "34674647"
  },
  {
    "drug": "DCDC2",
    "target": "Dyslexia",
    "cancer": "Type 2 Diabetes",
    "variant": "Associated gene",
    "pmid": "34674647"
  },
  {
    "drug": "KIAA0319",
    "target": "Dyslexia",
    "cancer": "Type 2 Diabetes",
    "variant": "Associated gene",
    "pmid": "34674647"
  },
  {
    "drug": "MRPL19",
    "target": "Dyslexia",
    "cancer": "Type 2 Diabetes",
    "variant": "Associated gene",
    "pmid": "34674647"
  },
  {
    "drug": "Leptin",
    "target": "LEPR (Leptin receptor)",
    "cancer": "Leptinoma",
    "pmid": "32823525"
  },
  {
    "drug": "Insulin",
    "target": "Insulin receptor",
    "cancer": "Insulinoma",
    "pmid": "32823525"
  },
  {
    "drug": "p53 modulator",
    "target": "TP53 (p53 tumor suppressor gene)",
    "cancer": "Breast Cancer",
    "pmid": "32823525"
  },
  {
    "drug": "p53 reactivation and cancer repair (PRCR)",
    "target": "TP53 (p53 tumor suppressor gene)",
    "cancer": "Colon Cancer",
    "pmid": "32823525"
  },
  {
    "drug": "MYC inhibitor",
    "target": "MYC (Proto-oncogene)",
    "cancer": "Lymphoma",
    "pmid": "32823525"
  },
  {
    "drug": "CYP2D6 substrate",
    "target": "CYP2D6 (Cytochrome P450 2D6)",
    "cancer": "Breast Cancer",
    "pmid": "32823525"
  },
  {
    "drug": "CYP1B1 inhibitor",
    "target": "CYP1B1 (Cytochrome P450 1B1)",
    "cancer": "Prostate Cancer",
    "pmid": "32823525"
  },
  {
    "drug": "SLC2A13 modulator",
    "target": "SLC2A13 (Glucose transporter type 13)",
    "cancer": "Pancreatic Cancer",
    "pmid": "32823525"
  },
  {
    "drug": "ARNT inhibitor",
    "target": "ARNT (aryl hydrocarbon receptor nuclear translocator)",
    "cancer": "Lung Cancer",
    "pmid": "32823525"
  },
  {
    "drug": "APOC1/APOC2 activator",
    "target": "APOC1/APOC2 (Apolipoproteins)",
    "cancer": "HDL-related disorders (may relate to cancer)",
    "pmid": "32823525"
  },
  {
    "drug": "SLC33A1 inhibitor",
    "target": "SLC33A1 (Solute carrier family 33 member A1)",
    "cancer": "Metastasis",
    "pmid": "32823525"
  },
  {
    "drug": null,
    "target": null,
    "cancer": null,
    "genetic_variant": null,
    "disease": null,
    "pmid": "32477452"
  },
  {
    "drug": "omega-3/6 fatty acids",
    "target": "SLC39 (including SLC39A8)",
    "condition": "Type 2 Diabetes",
    "relevant_phenotype": "Type 2 Diabetes",
    "pmid": "38496672"
  },
  {
    "drug": "immunomodulatory",
    "target": "HLA-DRB1",
    "condition": "Alzheimer's disease",
    "relevant_phenotype": "Alzheimer's disease",
    "pmid": "38496672"
  },
  {
    "drug": "immunomodulatory",
    "target": "HLA-DRB1",
    "condition": "Bipolar disorder",
    "relevant_phenotype": "Bipolar disorder",
    "pmid": "38496672"
  },
  {
    "drug": "immunomodulatory",
    "target": "HLA-DRB1",
    "condition": "Tourette's syndrome",
    "relevant_phenotype": "Tourette's syndrome",
    "pmid": "38496672"
  },
  {
    "drug": "immunomodulatory",
    "target": "SLC39A8",
    "condition": "Type 2 Diabetes",
    "relevant_phenotype": "Type 2 Diabetes",
    "pmid": "38496672"
  },
  {
    "drug": "antihypertensive",
    "target": "SLC39A8",
    "condition": "Type 2 Diabetes",
    "relevant_phenotype": "Type 2 Diabetes",
    "pmid": "38496672"
  },
  {
    "drug": "cholesterol-lowering",
    "target": "SLC39A8",
    "condition": "Type 2 Diabetes",
    "relevant_phenotype": "Type 2 Diabetes",
    "pmid": "38496672"
  },
  {
    "drug": "immunomodulatory",
    "target": "HLA-DRB1",
    "condition": "Alzheimer's disease",
    "relevant_phenotype": "Alzheimer (AD)",
    "pmid": "38496672"
  },
  {
    "drug": "immunomodulatory",
    "target": "HLA-DRB1",
    "condition": "Bipolar disorder",
    "relevant_phenotype": "Bipolar disorder",
    "pmid": "38496672"
  },
  {
    "drug": "immunomodulatory",
    "target": "HLA-DRB1",
    "condition": "Tourette's syndrome",
    "relevant_phenotype": "Tourette's syndrome",
    "pmid": "38496672"
  },
  {
    "drug": "omega-3/6 fatty acids",
    "target": "SLC39A8",
    "cancer": null,
    "pmid": "40221434"
  },
  {
    "drug": "immunomodulatory drugs",
    "target": "HLA-DRB1",
    "cancer": null,
    "pmid": "40221434"
  }
]